tiprankstipranks
Genmab A/S (GMAB)
NASDAQ:GMAB
US Market
GMAB
Genmab
RESEARCH TOOLSreports

Genmab (GMAB) Income Statement

777 Followers

Genmab Income Statement

Last quarter (Q4 2025), Genmab's total revenue was kr1.05B, a decrease of -83.62% from the same quarter last year. In Q4, Genmab's net income was kr30.91M. See Genmab’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
kr 3.72Bkr 21.53Bkr 16.47Bkr 14.51Bkr 8.42B
Gross Profit
kr 3.41Bkr 20.54Bkr 16.25Bkr 14.51Bkr 8.42B
Operating Expenses
kr 2.16Bkr 13.84Bkr 10.93Bkr 8.24Bkr 5.46B
Depreciation and Amortization
kr 71.06Mkr 413.00Mkr 240.00Mkr 362.00Mkr 250.00M
EBITDA
kr 1.32Bkr 9.70Bkr 5.95Bkr 7.35Bkr 4.18B
Operating Income
kr 1.25Bkr 6.70Bkr 5.32Bkr 6.27Bkr 2.95B
Other Income/Expenses
kr -46.04Mkr 2.46Bkr 316.00Mkr 678.00Mkr 965.00M
Pretax Income
kr 1.20Bkr 9.16Bkr 5.64Bkr 6.95Bkr 3.92B
Net Income
kr 963.76Mkr 7.84Bkr 4.35Bkr 5.45Bkr 2.96B
Per Share Metrics
Basic EPS
kr 1.55kr 12.14kr 6.60kr 8.34kr 4.52
Diluted EPS
kr 1.54kr 12.14kr 6.60kr 8.26kr 4.48
Weighted Average Shares Outstanding
 621.51M 646.34M 659.19M 653.87M 653.96M
Weighted Average Shares Outstanding (Diluted)
 626.92M 646.33M 659.15M 660.10M 660.46M
Currency in DKK

Genmab Earnings and Revenue History